Citadel Advisors - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 198 filers reported holding NOVOCURE LTD in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$13,330,388
-48.7%
825,411
+31.9%
0.00%
-66.7%
Q2 2023$25,963,894
+86.9%
625,636
+170.8%
0.01%
+100.0%
Q1 2023$13,893,122
-59.7%
231,013
-50.8%
0.00%
-62.5%
Q4 2022$34,474,867
-3.1%
470,005
+0.4%
0.01%0.0%
Q3 2022$35,583,000
-36.4%
468,336
-41.8%
0.01%
-42.9%
Q2 2022$55,964,000
+8.4%
805,224
+29.3%
0.01%
+27.3%
Q1 2022$51,614,000
+41.9%
622,977
+28.6%
0.01%
+37.5%
Q4 2021$36,374,000
-35.9%
484,469
-0.8%
0.01%
-27.3%
Q3 2021$56,720,000
-32.0%
488,254
+29.8%
0.01%
-42.1%
Q2 2021$83,438,000
+98.4%
376,149
+18.2%
0.02%
+90.0%
Q1 2021$42,053,000
-39.7%
318,144
-21.0%
0.01%
-44.4%
Q4 2020$69,695,000
+17.3%
402,767
-24.6%
0.02%0.0%
Q3 2020$59,422,000
+201.3%
533,849
+60.5%
0.02%
+157.1%
Q2 2020$19,720,000
-2.4%
332,537
+10.9%
0.01%
-22.2%
Q1 2020$20,196,000
+22.3%
299,912
+53.1%
0.01%
+28.6%
Q4 2019$16,514,000
+42.4%
195,956
+26.4%
0.01%
+16.7%
Q3 2019$11,595,000
+112.4%
155,051
+79.6%
0.01%
+100.0%
Q2 2019$5,459,000
-35.0%
86,353
-50.5%
0.00%
-25.0%
Q1 2019$8,395,000
-16.5%
174,291
-41.9%
0.00%
-20.0%
Q4 2018$10,050,000
+33.4%
300,216
+108.8%
0.01%
+66.7%
Q3 2018$7,536,000
-66.8%
143,805
-80.1%
0.00%
-72.7%
Q2 2018$22,668,000
-17.4%
724,236
-42.4%
0.01%
-26.7%
Q1 2018$27,427,000
+166.6%
1,258,087
+147.0%
0.02%
+150.0%
Q4 2017$10,287,000
+139.0%
509,262
+134.8%
0.01%
+50.0%
Q3 2017$4,305,000
+260.6%
216,865
+214.3%
0.00%
+300.0%
Q2 2017$1,194,000
+509.2%
69,004
+184.1%
0.00%
Q1 2017$196,000
+49.6%
24,291
+45.3%
0.00%
Q4 2016$131,000
-49.8%
16,722
-7.4%
0.00%
Q1 2016$261,00018,0490.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2019
NameSharesValueWeighting ↓
StepStone Group LP 115,479$7,302,00011.05%
HARTLINE INVESTMENT CORP/ 335,585$21,219,0005.07%
Darsana Capital Partners LP 1,500,000$94,845,0003.08%
Rhenman & Partners Asset Management AB 365,899$23,136,0002.55%
COURAGE CAPITAL MANAGEMENT LLC 20,000$1,265,0002.15%
Taylor Frigon Capital Management LLC 46,599$2,946,0002.04%
Granite Investment Partners, LLC 411,659$26,029,0001.40%
Nicholas Investment Partners, LP 146,106$9,238,0000.85%
Baillie Gifford 8,829,449$558,287,0000.59%
Cortina Asset Management, LLC 141,352$8,938,0000.55%
View complete list of NOVOCURE LTD shareholders